Supreme Court: Courts Have Sometimes Failed Arbitration, With Interference Curing No Disease  ||  Supreme Court: Co-Heir Cannot Sell Other Heirs' Shares as Karta After Intestate Succession  ||  SC: Casual Labourers With Temporary Status are Eligible For Pension Even Without Regularisation  ||  Supreme Court: High Courts Must Record the Nature of Crime and Allegations While Quashing FIRs  ||  Delhi HC Rejected Pernod Ricard’s Plea Against Denial of Wholesale Liquor License over Excise Case  ||  Gujarat HC: Lalita Kumari Ruling Does Not Permit Deceased’s Kin to Invoke Art 226 For FIR Failure  ||  Ker HC: Denying Disability Pension to Army Personnel Based on Unreasoned Medical Opinion is Invalid  ||  Kerala HC Directs Family Courts to Follow Calcutta HC Custody Guidelines Till State Rules Framed  ||  Allahabad HC Allows LIC Employees to Be Engaged as Census Enumerators and Supervisors For Duties  ||  Supreme Court Unveiled Victim Protection Plan For Trafficking Survivors and Urged Legal Reforms    

National Pharmaceutical Pricing Authority Notifies All Medical Devices Under Price Control - (02 Apr 2020)

LAW OF MEDICINE

National Pharmaceutical Pricing Authority has notified all medical devices sold in India as ‘drugs’ to bring the devices — such as syringes, needles, cardiac stents, a knee implant, digital thermometers, CT scan, MRIs and dialysis machines — under the purview of price control and prohibit firms from hiking their costs by more than 10% annually at a time.

Tags : NATIONAL PHARMACEUTICAL PRICING AUTHORITY   ALL MEDICAL DEVICES UNDER PRICE CONTROL  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved